Diabetes Devices Market AnalysisWill Escalate Rapidly in the Near Future 2027

• • • According to Transparency Market Research's latest report on the global diabetes devices market for the historical period 2017–2018 and forecast period 2019–2027, increase in prevalence of diabetes, and increase in adoption of insulin pumps among type 1 diabetes patients are projected to drive the global diabetes devices market during the forecast period
    • According to the report, the global diabetes devices market was valued at US $ 41.8 Bn in 2018 and is anticipated to expand at a CAGR of 6.4% from 2019 to 2027

    To know the scope of our report  Get a Sample  on Diabetes Devices Market?

    Increase in Prevalence of Diabetes Expected to Drive Global Diabetes Devices Market: Key Drivers

    • Prevalence of diabetes is expected to increase exponentially worldwide due to change in lifestyle and various factors such as malnutrition, genetic mutations, and others. According to various government and private organizations operating in the diabetes industry, diabetes is considered one of the top fatal diseases. For instance, according to the American Diabetes Association, diabetes accounts for nearly 71,000 deaths in the US each year. About 1 in 11 adults in the country suffers from diabetes.
    • Rise in prevalence of diabetes across the US and Asia is anticipated to boost the growth of the diabetes management market due to a relative increase in demand for  insulin delivery devices
    • According to the International Diabetes Federation, 422 million people across the world were living with diabetes in 2016, and over 10% of the world's adult population, or around 642 million people, will have diabetes by 2040. Hence, increase in the diabetic population in Asia and the US is expected to propel the diabetes devices market.

    Get a glimpse of the in-depth analysis through our  Report Brochure

    Increase in Adoption of Insulin Pump among Type 1 Diabetes Patients Boost Market Growth

    • Over the last decade, Type 1 diabetes has been one of the increasing in major healthcare concern for many countries. Countries like the US, China, UK, and Germany have seen increasing rates of T1 incidences.
    • Type 1 diabetes (T1D) is type of autoimmune disease which occurs in children and adults in which pancreas stops producing insulin. The increasing incidences of Type 1 diabetes (T1D) among the children’s is one of the major healthcare concern. For instance, according to IDF, in 2015 Europe region had 140,000 children’s (0-14 years) with Type-1 Diabetes and 21,600 new cases diagnosed every year.
    • Type-1 diabetes patients majorly use the insulin pen or insulin pumps. Insulin pumps are relatively costly as compared to other insulin delivery devices. However, the adoption of insulin pumps among is increasing gradually in many developing and developed countries.
    • This increasing incidences of type-1 diabetes in developing and developed countries are expected to drive the growth of the global insulin pumps market.

    Request the Coronavirus Impact Analysis on this  Markets - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=14

    Threat of Alternative Therapies for Diabetes to Hamper Market

    • Diabetes is a dreadful disease that is becoming a serious threat to human health. Rise in obesity and sedentary lifestyle have become a major cause of increasing diabetes prevalence across the world.
    • Various treatments and drugs are available for diabetes. However, total recovery from diabetes is still a matter of concern. Alternative to synthetic agents, natural cure by plants provides a potential source curing complications of hypoglycemia.
    • Other alternative therapies such as acupuncture, diabetic supplements, hydrotherapy, and yoga are practiced for treatment of diabetes and have no side effects
    • These emerging alternative therapies are likely to act as major restraints of the diabetes device market

    Expanding operations in future? To get the perfect launch ask for a custom report 

    Global Diabetes Devices Market: Competitive Landscape

    • This report profiles major players in the global diabetes devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
    • The global diabetes devices market is highly fragmented, with the presence of a number of international as well as regional players
    • Leading players operating in the global diabetes devices market are
      • Medtronic
      • Novo Nordisk A/S
      • Sanofi
      • Eli Lilly and Company
      • F. Hoffmann-La Roche Ltd.
      • Becton
      • Dickinson and Company
      • Tandem Diabetes Care, Inc.
      • Abbott Laboratories
      • Cellnovo
      • Insulet Corporation
      • LifeScan, Inc.
      • Owen Mumford Ltd.

    More Trending Reports by Transparency Market Research - 

    Digital Dose Inhalers Market: http://www.prnewswire.com/news-releases/global-digital-dose-inhalers-market-to-reach-a-value-of-us-4-3-bn-by-2027 –Growing-at-a-cagr-of-10-from-2019-to-2027-transparency-market-research-300999357.html